387 related articles for article (PubMed ID: 23063971)
21. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
22. Statins and cancer risk: a meta-analysis.
Dale KM; Coleman CI; Henyan NN; Kluger J; White CM
JAMA; 2006 Jan; 295(1):74-80. PubMed ID: 16391219
[TBL] [Abstract][Full Text] [Related]
23. Statin use and risk of hepatocellular carcinoma in a U.S. population.
McGlynn KA; Divine GW; Sahasrabuddhe VV; Engel LS; VanSlooten A; Wells K; Yood MU; Alford SH
Cancer Epidemiol; 2014 Oct; 38(5):523-7. PubMed ID: 25113938
[TBL] [Abstract][Full Text] [Related]
24. Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies.
Islam MM; Poly TN; Walther BA; Yang HC; Jack Li YC
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183029
[No Abstract] [Full Text] [Related]
25. Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis.
Yang Y; Zhang D; Feng N; Chen G; Liu J; Chen G; Zhu Y
Gastroenterology; 2014 Nov; 147(5):1031-42. PubMed ID: 25127680
[TBL] [Abstract][Full Text] [Related]
26. Statin use and virus-related cirrhosis: A systemic review and meta-analysis.
Ma X; Sun D; Li C; Ying J; Yan Y
Clin Res Hepatol Gastroenterol; 2017 Oct; 41(5):533-542. PubMed ID: 28866088
[TBL] [Abstract][Full Text] [Related]
27. Statin use and risk of hepatocellular carcinoma.
Lai SW; Liao KF; Lai HC; Muo CH; Sung FC; Chen PC
Eur J Epidemiol; 2013 Jun; 28(6):485-92. PubMed ID: 23681775
[TBL] [Abstract][Full Text] [Related]
28. [Meta-analysis of the effects of statins on the risk of chronic liver disease and hepatocellular carcinoma].
Wei J; Lvy JH; Sun XJ; Wu XR
Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):696-701. PubMed ID: 34371542
[No Abstract] [Full Text] [Related]
29. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract][Full Text] [Related]
30. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.
Khajeh E; Moghadam AD; Eslami P; Ali-Hasan-Al-Saegh S; Ramouz A; Shafiei S; Ghamarnejad O; Dezfouli SA; Rupp C; Springfeld C; Carvalho C; Probst P; Mousavizadeh SM; Mehrabi A
BMC Cancer; 2022 Jan; 22(1):91. PubMed ID: 35062904
[TBL] [Abstract][Full Text] [Related]
31. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis.
Arvind A; Memel ZN; Philpotts LL; Zheng H; Corey KE; Simon TG
Metabolism; 2021 Jul; 120():154780. PubMed ID: 33891949
[TBL] [Abstract][Full Text] [Related]
32. Statin use and risk of Parkinson's disease: A meta-analysis.
Sheng Z; Jia X; Kang M
Behav Brain Res; 2016 Aug; 309():29-34. PubMed ID: 27131781
[TBL] [Abstract][Full Text] [Related]
33. Combined Use of Aspirin and Statin is Associated With a Decreased Incidence of Hepatocellular Carcinoma.
Singh J; Wozniak A; Cotler SJ; Dhanarajan A; Aldrich D; Park D; Kasia C; Schmidt B; Scaglione S
J Clin Gastroenterol; 2022 Apr; 56(4):369-373. PubMed ID: 33883511
[TBL] [Abstract][Full Text] [Related]
34. Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis.
Singh PP; Singh S
Ann Oncol; 2013 Jul; 24(7):1721-1730. PubMed ID: 23599253
[TBL] [Abstract][Full Text] [Related]
35. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.
Tsan YT; Lee CH; Ho WC; Lin MH; Wang JD; Chen PC
J Clin Oncol; 2013 Apr; 31(12):1514-21. PubMed ID: 23509319
[TBL] [Abstract][Full Text] [Related]
36. Bisphosphonates are associated with reduced risk of colorectal cancer: a systematic review and meta-analysis.
Singh S; Singh AG; Murad MH; Limburg PJ
Clin Gastroenterol Hepatol; 2013 Mar; 11(3):232-9.e1. PubMed ID: 23220165
[TBL] [Abstract][Full Text] [Related]
37. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
[TBL] [Abstract][Full Text] [Related]
38. Chemopreventive strategies in hepatocellular carcinoma.
Singh S; Singh PP; Roberts LR; Sanchez W
Nat Rev Gastroenterol Hepatol; 2014 Jan; 11(1):45-54. PubMed ID: 23938452
[TBL] [Abstract][Full Text] [Related]
39. Statin Use and the Risk of Cataracts: A Systematic Review and Meta-Analysis.
Yu S; Chu Y; Li G; Ren L; Zhang Q; Wu L
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28320745
[TBL] [Abstract][Full Text] [Related]
40. Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
Cho Y; Kim MS; Nam CM; Kang ES
Sci Rep; 2019 Feb; 9(1):1467. PubMed ID: 30728421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
